Showing results (931-940 of 1,010) with videos related to

Sort By:
Pageof 101
Cardiovascular Therapeutics|October 14, 2014
Effect of tocopherol on atherosclerosis, vascular function, and inflammation in apolipoprotein E knockout mice with subtotal nephrectomyCecilia M Shing, Robert G Fassett, Jonathan M Peake, et al.
Cardiovascular Therapeutics|November 12, 2013
Parachute implant: CT morphological criteria of our center to identify the suitable patientIlkay Bozdag-Turan, Benjamin Bermaoui, R Goekmen Turan, et al.
Cardiovascular Therapeutics|December 16, 2017
Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai populationSupatat Chumnumwat, Kong Yi, Aroonrut Lucksiri, et al.
Cardiovascular Therapeutics|November 25, 2017
The effect of allogeneic cardiac stem cells in left ventricular geometry and function in a rat model of myocardial infarctionYinlun Weng, Xueyuan Zhang, Anmin Liu, et al.
Cardiovascular Therapeutics|February 28, 2018
Effects of combination of sotalol and verapamil on initiation, maintenance, and termination of ventricular fibrillation in swine heartsQi Jin, Liqun Wu, Derek J Dosdall, et al.
Cardiovascular Therapeutics|May 26, 2018
Chronic median nerve modulation reduces ventricular arrhythmia and improves ventricular function in a postmyocardial infarction rabbit modelZhengqin Zhai, Shuang Zhao, Min Tang, et al.
Cardiovascular Therapeutics|June 22, 2017
Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 UpregulationYang Bai, Qiang Chen, Yun-Peng Sun, et al.
Cardiovascular Therapeutics|June 10, 2017
Exploring the putative role of TRPV1 -dependent CGRP release in remote hind preconditioning-induced cardioprotectionPuneet Kaur Randhawa, Amteshwar Singh Jaggi
Cardiovascular Therapeutics|July 19, 2018
Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure populationAnna Jonsson, Helena Norberg, Ellinor Bergdahl, et al.
Cardiovascular Therapeutics|July 19, 2018
Trimetazidine suppresses oxidative stress, inhibits MMP-2 and MMP-9 expression, and prevents cardiac rupture in mice with myocardial infarctionWei Gong, Youcai Ma, Aobo Li, et al.
Pageof 101